Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
용도 변경 구충제 조합의 상승적 항 SARS-CoV-2 활성
Article
[키워드] Analysis
anti-parasitic drug
Anti-parasitic drugs
Anti-SARS-CoV-2 Activity
antiviral drug
antiviral drugs
approach
benefit
Calu
Calu-3
calu-3 cells
Chloroquine
claimed
clinical trials
Combination
combinations
country
COVID-19 pandemic
demonstrated
drug
drug combination
drug combinations
drugs
Economy
effective
Effectiveness
ENhance
epithelial cells
evaluated
Health Service
highest
in vitro
inhibitory
inhibitory concentration
Ivermectin
Lung epithelial cells
niclosamide
pandemic
reduction in
Repurposed drug
repurposing
resulting
SARS-CoV-2
shown
Spread
synergistic
synergy
tested
Treatment
vaccination
Vero E6
Vero E6 cell
VERO E6 cells
[DOI] 10.1186/s40360-022-00580-8 PMC 바로가기 [Article Type] Article
[DOI] 10.1186/s40360-022-00580-8 PMC 바로가기 [Article Type] Article